0 136

Cited 10 times in

A laboratory association between hemoglobin and VerifyNow P2Y12 reaction unit: A systematic review and meta-analysis

Authors
 Yun Gi Kim  ;  Jung-Won Suh  ;  Dirk Sibbing  ;  Adnan Kastrati  ;  Young-Guk Ko  ;  Yangsoo Jang  ;  Young-Seok Cho  ;  Tae-Jin Youn  ;  In-Ho Chae  ;  Dong-Ju Choi  ;  Hyo-Soo Kim 
Citation
 AMERICAN HEART JOURNAL, Vol.188 : 53-64, 2017-06 
Journal Title
AMERICAN HEART JOURNAL
ISSN
 0002-8703 
Issue Date
2017-06
MeSH
Blood Platelets / drug effects* ; Coronary Artery Disease / blood ; Coronary Artery Disease / drug therapy* ; Hemoglobins / metabolism* ; Humans ; Platelet Aggregation / drug effects* ; Platelet Function Tests ; Purinergic P2Y Receptor Antagonists / pharmacology*
Abstract
Background: VerifyNow P2Y12 assay is used widely to evaluate residual platelet reactivity in patients taking P2Y12 receptor antagonists. However, a laboratory association between VerifyNow P2Y12 reaction unit (PRU) and hemoglobin, which might lead to wrong interpretation of the data, is reported. We performed these systematic review and meta-analysis to clearly define the relationship between PRU and hemoglobin and to elucidate whether the relationship, if any, is a true biological association or is just a laboratory error.

Methods: Through a comprehensive electronic and manual search, 10 studies were selected for the cohort level meta-analysis. Among 10 studies, we were able to retrieve the raw data of 5 studies, and a patient-level meta-analysis was performed. Potential publication bias was searched by funnel plot analysis and was actively adjusted, if present, by trim and fill method.

Results: The pooled analysis revealed a significant inverse correlation between PRU and hemoglobin (r=-0.349; P<.001; 10 studies with 4,793 patients). VerifyNow P2Y12 base unit, which reflects off-drug platelet reactivity, was also inversely correlated with hemoglobin (r=-0.526; P<.001; 8 studies with 4,395 patients). % Inhibition (r=0.081; P=.059; 6 studies with 3,832 patients) and ΔPRU (r=-0.037; P=.188; 5 studies with 3,521 patients) were not associated with hemoglobin. A significant inverse association between PRU and hemoglobin was also observed in the patient-level meta-analysis (3,533 patients pooled from 5 studies; r=-0.335; P<.001). Light transmission aggregometry (r=0.160; P=.072; 4 studies with 1,144 patients) and multiple electrode platelet aggregometry (r=-0.029; P=.394; 3 studies with 7,645 patients) showed no significant association with hemoglobin.

Conclusions: A significant inverse association was observed between PRU and hemoglobin which is likely to be a laboratory error. Clinicians should be aware that this association might lead to wrong interpretation of the data.
Full Text
https://www.sciencedirect.com/science/article/pii/S000287031730087X
DOI
10.1016/j.ahj.2017.03.006
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Ko, Young Guk(고영국) ORCID logo https://orcid.org/0000-0001-7748-5788
Jang, Yang Soo(장양수) ORCID logo https://orcid.org/0000-0002-2169-3112
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/196107
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links